Triage-driven diagnosis of Barrett's esophagus for early detection of esophageal adenocarcinoma using deep learning.
Marcel GehrungMireia Crispin-OrtuzarAdam G BermanMaria O'DonovanRebecca C FitzgeraldFlorian MarkowetzPublished in: Nature medicine (2021)
Deep learning methods have been shown to achieve excellent performance on diagnostic tasks, but how to optimally combine them with expert knowledge and existing clinical decision pathways is still an open challenge. This question is particularly important for the early detection of cancer, where high-volume workflows may benefit from (semi-)automated analysis. Here we present a deep learning framework to analyze samples of the Cytosponge-TFF3 test, a minimally invasive alternative to endoscopy, for detecting Barrett's esophagus, which is the main precursor of esophageal adenocarcinoma. We trained and independently validated the framework on data from two clinical trials, analyzing a combined total of 4,662 pathology slides from 2,331 patients. Our approach exploits decision patterns of gastrointestinal pathologists to define eight triage classes of varying priority for manual expert review. By substituting manual review with automated review in low-priority classes, we can reduce pathologist workload by 57% while matching the diagnostic performance of experienced pathologists.
Keyphrases
- deep learning
- artificial intelligence
- convolutional neural network
- clinical trial
- emergency department
- minimally invasive
- machine learning
- squamous cell carcinoma
- newly diagnosed
- healthcare
- end stage renal disease
- ejection fraction
- big data
- high throughput
- clinical practice
- locally advanced
- electronic health record
- radiation therapy
- decision making
- randomized controlled trial
- patient reported outcomes
- rectal cancer
- data analysis
- young adults
- high intensity
- phase ii
- phase iii